25 May 2013
Keywords: celgene, reports, initial, figures, drugmaker, forecast, revenue
Article | 26 January 2009
US drugmaker Celgene has forecast total revenue for 2008 of around $2.23 billion, due to rocketing sales of its oncology drug Revlimid
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
26 January 2009
24 May 2013
© 2013 thepharmaletter.com